Genome-wide gene expression profiling of SCID mice with T-cell-mediated colitis

Scandinavian Journal of Immunology

Volumn 69, Issue 5, 2009, Pages 437-446

  Brudzewsky, D ^a   Pedersen, A E ^a   Claesson, M H ^a   Gad, M ^a   Kristensen, N N ^a   Lage, K ^b   Jensen, T ^b   Tommerup, N ^a   Larsen, L A ^a   Knudsen, S ^b   Tumer Z ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CONCANAVALIN A; MOLECULAR MARKER; PROTEIN S 100; PROTEIN S 100S; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFER; CELLULAR IMMUNITY; COLITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE PROBE; GENOME; HISTOLOGY; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; LEUKOCYTE; MOUSE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; RECTUM; SCID MOUSE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; CHROMOSOME MAPPING; CLUSTER ANALYSIS; COLITIS; COLON; CONCANAVALIN A; FEMALE; GENE EXPRESSION PROFILING; GENOME; GENOME, HUMAN; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED BALB C; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNTENY; T-LYMPHOCYTES;

EID: 64549132570     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02243.x     Document Type: Article

References (52)

1. Strober W, Fuss IJ. Experimental models of mucosal inflammation. Adv Exp Med Biol 2006 579 : 55 97.
2. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005 6 : 376 88.
3. Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology 2007 133 : 1670 89.
4. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983 300 : 527 30.
5. Brimnes J, Reimann J, Nissen M, Claesson MH. Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease. Eur J Immunol 2001 31 : 23 31.
6. Kullberg MC, Andersen JF, Gorelick PL et al. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc Natl Acad Sci U S A 2003 100 : 15830 5.
7. Claesson MH, Rudolphi A, Kofoed S, Poulsen SS, Reimann J. CD4+ T lymphocytes injected into scid mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996 104 : 491 500.
8. Bregenholt S. Cells and cytokines in the pathogenesis of inflammatory bowel disease: new insights from mouse T cell transfer models. Exp Clin Immunogenet 2000 17 : 115 29.
9. Claesson MH, Bregenholt S, Bonhagen K et al. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL- responsiveness, and CD45RB surface phenotype. J Immunol 1999 162 : 3702 10.
10. Moller PL, Paerregaard A, Gad M, Kristensen NN, Claesson MH. Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis 2005 11 : 814 9.
11. Knudsen S, Workman C, Sicheritz-Ponten T, Friis C. Genepublisher: automated analysis of DNA microarray data. Nucleic Acids Res 2003 31 : 3471 6.
12. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003 19 : 185 93.
13. Dennis G Jr., Sherman BT, Hosack DA et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003 4 : P3.
14. Kristensen NN, Olsen J, Gad M, Claesson MH. Genome-wide expression profiling during protection from colitis by regulatory T cells. Inflamm Bowel Dis 2008 14 : 75 87.
15. te Velde AA, de Kort F, Sterrenburg E et al. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis 2007 13 : 325 30.
16. Dooley TP, Curto EV, Reddy SP et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004 10 : 1 14.
17. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000 4 : 1 11.
18. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001 10 : 445 56.
19. Okahara S, Arimura Y, Yabana T et al. Inflammatory gene signature in ulcerative colitis with cDNA macroarray analysis. Aliment Pharmacol Ther 2005 21 : 1091 7.
20. Rivera E, Flores I, Rivera E, Appleyard CB. Molecular profiling of a rat model of colitis: validation of known inflammatory genes and identification of novel disease-associated targets. Inflamm Bowel Dis 2006 12 : 950 66.
21. Heller RA, Schena M, Chai A et al. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci USA 1997 94 : 2150 5.
22. Burczynski ME, Peterson RL, Twine NC et al. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn 2006 8 : 51 61.
23. Berger T, Togawa A, Duncan GS et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006 103 : 1834 9.
24. Kanneganti TD, Lamkanfi F, Núnez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007 27 : 549 59.
25. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007 81 : 1 5.
26. Melle C, Ernst G, Schimmel B et al. Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol 2006 28 : 195 200.
27. Cecil DL, Johnson K, Rediske J, Lotz M, Schmidt AM, Terkeltaub R. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 2005 175 : 8296 302.
28. Makino E, Sakaguchi M, Iwatsuki K, Huh NH. Introduction of an N-terminal peptide of S100C/A1 into human cells induces apoptotic cell death. J Mol Med 2004 82 : 612 20.
29. Bregenholt S, Claesson MH. Increased intracellular Th cytokines in scid mice with inflammatory bowel disease. Eur J Immunol 1998 28 : 379 89.
30. Scheerens H, Hessel E, de Waal-Malefyt R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 2001 31 : 1465 74.
31. Oki M, Ohtani H, Kinouchi Y et al. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response? Lab Invest 2005 85 : 137 45.
32. Keates S, Keates AC, Mizoguchi E, Bhan A, Kelly CP. Enterocytes are the primary source of the chemokine ENA-7 in normal colon and ulcerative colitis. Am J Physiol 1997 273 : G75 82.
33. Williams AM, Whiting CV, Bonhagen K et al. Tumour necrosis factor-alpha (TNF-alpha) transcription and translation in the CD4+ T cell-transplanted scid mouse model of colitis. Clin Exp Immunol 1999 116 : 415 24.
34. Bregenholt S, Brimnes J, Nissen MH, Claesson MH. In vitro activated CD4+ T cells from interferon-gamma (IFN-gamma)-deficient mice induce intestinal inflammation in immunodeficient hosts. Clin Exp Immunol 1999 118 : 228 34.
35. Blam ME, Stein RB, Lichtenstein GR. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives. Am J Gastroenterol 2001 96 : 1977 97.
36. Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL. Interleukin-1 regulates expression of the CXC chemokine LIX/CXCL in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 2004 76 : 135 44.
37. Sieveking D, Mitchell HM, Day AS. Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro. J Gastroenterol Hepatol 2004 19 : 982 7.
38. Bregenholt S, Brimnes J, Reimann J, Claesson MH. Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in the severe combined immunodeficient (scid) mice with T cell-induced inflammatory bowel disease (IBD). Clin Exp Immunol 1998 114 : 19 25.
39. Carlsen HS, Baekkevold ES, Johansen FE, Haraldsen G, Brandtzaeg P. B cell attracting chemokine (CXCL13) and its receptor CXCR are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002 51 : 364 71.
40. Steinmetz OM, Panzer U, Kneissler U et al. BCA-1/CXCL1 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005 67 : 1616 21.
41. Subbaramaiah K, Yoshimatsu K, Scherl E et al. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 2004 279 : 12647 58.
42. Otani T, Yamaguchi K, Scherl E et al. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2006 290 : G361 8.
43. Oppermann UC, Persson B, Jornvall H. Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms. Eur J Biochem 1997 249 : 355 60.
44. de Buhr MF, Mahler M, Geffers R et al. Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol Genomics 2006 25 : 426 34.
45. Takahashi KI, Fukushima K, Sasano H et al. Type II 11beta-hydroxysteroid dehydrogenase expression in human colonic epithelial cells of inflammatory bowel disease. Dig Dis Sci 1999 44 : 2516 22.
46. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 1998 281 : 998 1001.
47. Costello CM, Mah N, Hasler R et al. Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2005 2 : e199.
48. Xia MQ, Tone M, Packman L, Hale G, Waldmann H. Characterization of the CAMPATH (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone. Eur J Immunol 1991 21 : 1677 84.
49. Mitchell DA, Taylor PR, Cook HT et al. Cutting edge: C1q protects against the development of glomerulonephritis independently of C activation. J Immunol 1999 162 : 5676 9.
50. Kaneda A, Wakazono K, Tsukamoto T et al. Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 2004 64 : 6410 5.
51. Erler JT, Bennewith KL, Nicolau M et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006 440 : 1222 6.
52. Kaufmann J, Mueller A, Voigt A et al. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis. Rheumatology (Oxford) 2003 42 : 314 20.